‘Gentle’ islet cell transplant cures mice of diabetes with few side effects, Stanford Medicine researchers (Dr. Seung Kim) say

Written By Diana L Sung

A technique developed at Stanford Medicine allows mice with diabetes to accept unmatched islet cells and durably restores blood sugar control without immunosuppression or graft-versus-host disease.

Diana L Sung
Previous

Stanford Medicine scientists pinpoint COVID-19 virus’s entry and exit ports inside our noses
Next

Researchers including Dr. Michael Snyder and Dr. Philip Tsao identify more than 1,000 genes linked to severe COVID-19